Enhancing the Bioavailability and Efficacy of Vismodegib for the Control of Skin Cancer: In Vitro and In Vivo Studies
Skin cancer is the most frequent cancer throughout the world. Vismodegib (VSD) is a hedgehog blocker approved for the prevention and treatment of skin cancer. VSD, however, is poorly bioavailable and has been linked to side effects. This work focused on designing a nano-invasome gel as a vehicle for...
Saved in:
Main Authors: | Heba F. Salem (Author), Amr Gamal (Author), Haitham Saeed (Author), Marwa Kamal (Author), Alaa S. Tulbah (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Improving Dermal Permeation on the Efficacy and Targeting of Liposome Nanoparticles as a Potential Treatment for Breast Cancer
by: Heba F. Salem, et al.
Published: (2021) -
Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer
by: Amr Gamal, et al.
Published: (2021) -
Assessment and characteristics of Erenumab therapy on migraine management
by: Haitham Saeed, et al.
Published: (2022) -
In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin as a Cancer Therapy
by: Fatma I. Abo El-Ela, et al.
Published: (2022) -
The Topical Nanodelivery of Vismodegib Enhances Its Skin Penetration and Performance <i>In Vitro</i> While Reducing Its Toxicity <i>In Vivo</i>
by: Maria Natalia Calienni, et al.
Published: (2021)